益豐藥房(603939.SH):董事長提議實施2024年度中期分紅
格隆匯7月15日丨益豐藥房(603939.SH)公佈,收到公司實際控制人、董事長高毅先生出具的《關於提議益豐大藥房連鎖股份有限公司實施2024年度中期分紅的函》。為提升公司投資價值,與投資者共享發展成果,增強投資者獲得感,踐行公司“以投資者為本”的發展理念。公司實際控制人、董事長高毅先生提議:在符合《公司章程》規定的利潤分配原則、保證公司正常經營和長遠發展的前提下,制定並實施2024年度中期分紅方案,建議以實施權益分派的股權登記日公司總股本為基數,向全體股東每10股派發現金紅利2.50元(含税)。具體利潤分配方案由公司結合自身經營情況並報董事會、監事會及股東大會審議確定。高毅先生承諾將在相關會議審議該事項時投“同意”票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.